SLSBio(Specialty Lab Solution Bio) Co., Ltd Q3 revenue KRW 1.7 billion, operating loss KRW 0.8 billion
AI summary · Not investment advice
SLS Bio sold KRW 1.7 billion in Q3 and lost KRW 0.8 billion from its main business, with sales up 459.7% from a year earlier and 27.8% from the prior quarter.
Operating profit · 3 months
KRW -810.5 million
Key facts
- Revenue (3 months)
- KRW 1.7 billion
- Net income (3 months)
- KRW -819.1 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 295.7 million
- Revenue (year to date)
- KRW 3.9 billion
- Operating profit (prior-year 3 months)
- KRW -1.8 billionOperating loss
- Operating profit (year to date)
- KRW -2.7 billionOperating loss
- Net income (prior-year 3 months)
- KRW -1.9 billionNet loss
- Net income (year to date)
- KRW -2.7 billionNet loss
Commentary
AI commentary · Not investment advice
What happened
SLS Bio filed its quarterly report for the third quarter on a standalone basis. Sales for the 3 months were KRW 1.66 billion (KRW 1,655,174,969). That compares with KRW 295.7 million in the same 3 months a year earlier. Sales rose 459.7% from a year earlier and 27.8% from the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was a loss of KRW 810.5 million. A year earlier it was a loss of KRW 1.80 billion. Net income (final profit after taxes and all other items) for the 3 months was a loss of KRW 819.1 million. A year earlier it was a loss of KRW 1.87 billion.
What changes for shareholders
For the year so far (January 1 to September 30), sales were KRW 3.91 billion. Operating loss was KRW 2.66 billion. Net loss was KRW 2.73 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
S